CD19 and neoplasm: Moreover, ERK5−/− CD19‐CAR‐T cells presented a lower exhausted phenotype in both tumor cells treated and KP‐10 induced deteriorated cells (Figure S18H,I, Supporting Information) (representative plots in Figure S20, Supporting Information).